Susan Dillon
6Patents
3h-index
12Co-inventors
46Inventor score
Filing activity: Aug 10, 1999 → Dec 21, 2004
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6548520B1 | Substituted imidazoles having anti-cancer and cytokine inhibitory activity | Emerging Cross-Sectional Technologies | 10 | Expired |
| US6875576B2 | Method for evaluating therapeutic efficacy | Physics | 3 | Expired |
| US6436971B2 | Use of PDE 4-specific inhibitors to reduce the severity of a bacterial infection after a respiratory viral infection | Human Necessities | 3 | Expired |
| US6323318A | Human protein kinases hYAK3-2 | Human Necessities | 0 | Expired |
| US6306604A | EPO primary response gene, EPRG3Spt | Human Necessities | 0 | Expired |
| US7744897B2 | Human immunodeficiency virus gp41 mimetibody polypeptides | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.